DE60220084D1 - Die verwendung einer spezifischen dosis von fondaparinux natrium zur behandlung des akuten koronaren syndroms - Google Patents
Die verwendung einer spezifischen dosis von fondaparinux natrium zur behandlung des akuten koronaren syndromsInfo
- Publication number
- DE60220084D1 DE60220084D1 DE60220084T DE60220084T DE60220084D1 DE 60220084 D1 DE60220084 D1 DE 60220084D1 DE 60220084 T DE60220084 T DE 60220084T DE 60220084 T DE60220084 T DE 60220084T DE 60220084 D1 DE60220084 D1 DE 60220084D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- acute coronary
- coronary syndrome
- specific dose
- fondaparinux sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01204323 | 2001-11-13 | ||
| EP01204323 | 2001-11-13 | ||
| PCT/EP2002/012482 WO2003041722A1 (en) | 2001-11-13 | 2002-11-07 | Use of specific dose of fondaparinux sodium for the treatment of acs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60220084D1 true DE60220084D1 (de) | 2007-06-21 |
| DE60220084T2 DE60220084T2 (de) | 2008-01-10 |
Family
ID=8181220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60220084T Expired - Lifetime DE60220084T2 (de) | 2001-11-13 | 2002-11-07 | Die verwendung einer spezifischen dosis von fondaparinux natrium zur behandlung des akuten koronaren syndroms |
Country Status (37)
| Country | Link |
|---|---|
| US (1) | US20040248848A1 (de) |
| EP (1) | EP1446131B1 (de) |
| JP (1) | JP4523276B2 (de) |
| KR (1) | KR20050044318A (de) |
| CN (1) | CN1602197A (de) |
| AP (1) | AP1820A (de) |
| AR (1) | AR037291A1 (de) |
| AT (1) | ATE361753T1 (de) |
| AU (1) | AU2002351915B2 (de) |
| BR (1) | BR0212915A (de) |
| CA (1) | CA2465776A1 (de) |
| CO (1) | CO5580790A2 (de) |
| CY (1) | CY1106765T1 (de) |
| DE (1) | DE60220084T2 (de) |
| DK (1) | DK1446131T3 (de) |
| EA (1) | EA007325B1 (de) |
| EC (1) | ECSP045041A (de) |
| ES (1) | ES2287343T3 (de) |
| GE (1) | GEP20074097B (de) |
| HK (1) | HK1070561A1 (de) |
| HR (1) | HRP20040303B1 (de) |
| HU (1) | HU228959B1 (de) |
| IL (2) | IL161114A0 (de) |
| IS (1) | IS2484B (de) |
| MA (1) | MA27071A1 (de) |
| ME (2) | MEP1108A (de) |
| MX (1) | MXPA04003045A (de) |
| NO (1) | NO20041320L (de) |
| NZ (1) | NZ552129A (de) |
| PE (1) | PE20030740A1 (de) |
| PL (1) | PL206008B1 (de) |
| PT (1) | PT1446131E (de) |
| RS (1) | RS50906B (de) |
| SI (1) | SI1446131T1 (de) |
| UA (1) | UA80399C2 (de) |
| WO (1) | WO2003041722A1 (de) |
| ZA (1) | ZA200402464B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090075910A1 (en) * | 2007-09-13 | 2009-03-19 | Protia, Llc | Deuterium-enriched fondaparinux |
| KR20170123345A (ko) * | 2015-03-20 | 2017-11-07 | 오르후스 우니베르시테트 | 지질단백질 대사 장애의 치료를 위한 pcsk9의 억제제 |
| US10688249B2 (en) * | 2015-06-11 | 2020-06-23 | Virchow Biotech Pvt. Ltd. | Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same |
| CN107595769A (zh) * | 2017-10-23 | 2018-01-19 | 上海博悦生物科技有限公司 | 一种磺达肝癸钠注射液组合物的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2662442A1 (fr) * | 1990-05-23 | 1991-11-29 | Midy Spa | Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant. |
| CA2199642C (en) * | 1997-03-10 | 2001-05-08 | Roger Cariou | Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of an anti-xa oligosaccharide optionally in combination with aspirin |
| FR2764511B1 (fr) * | 1997-06-13 | 2000-09-08 | Sanofi Sa | Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire |
| AU2003225182B2 (en) * | 2002-04-25 | 2009-02-26 | Momenta Pharmaceuticals, Inc. | Methods and products for mucosal delivery |
-
2002
- 2002-07-11 UA UA2004032373A patent/UA80399C2/uk unknown
- 2002-11-07 HU HU0401462A patent/HU228959B1/hu unknown
- 2002-11-07 EP EP02787601A patent/EP1446131B1/de not_active Expired - Lifetime
- 2002-11-07 MX MXPA04003045A patent/MXPA04003045A/es active IP Right Grant
- 2002-11-07 ME MEP-11/08A patent/MEP1108A/xx unknown
- 2002-11-07 PT PT02787601T patent/PT1446131E/pt unknown
- 2002-11-07 DK DK02787601T patent/DK1446131T3/da active
- 2002-11-07 AU AU2002351915A patent/AU2002351915B2/en not_active Expired
- 2002-11-07 DE DE60220084T patent/DE60220084T2/de not_active Expired - Lifetime
- 2002-11-07 CA CA002465776A patent/CA2465776A1/en not_active Abandoned
- 2002-11-07 NZ NZ552129A patent/NZ552129A/en not_active IP Right Cessation
- 2002-11-07 ME MEP-2008-11A patent/ME00229B/me unknown
- 2002-11-07 PE PE2002001086A patent/PE20030740A1/es not_active Application Discontinuation
- 2002-11-07 RS YUP-267/04A patent/RS50906B/sr unknown
- 2002-11-07 US US10/492,102 patent/US20040248848A1/en not_active Abandoned
- 2002-11-07 WO PCT/EP2002/012482 patent/WO2003041722A1/en active IP Right Grant
- 2002-11-07 ES ES02787601T patent/ES2287343T3/es not_active Expired - Lifetime
- 2002-11-07 CN CNA028192567A patent/CN1602197A/zh active Pending
- 2002-11-07 JP JP2003543609A patent/JP4523276B2/ja not_active Expired - Fee Related
- 2002-11-07 IL IL16111402A patent/IL161114A0/xx unknown
- 2002-11-07 SI SI200230578T patent/SI1446131T1/sl unknown
- 2002-11-07 AP APAP/P/2004/003014A patent/AP1820A/en active
- 2002-11-07 PL PL369027A patent/PL206008B1/pl unknown
- 2002-11-07 AT AT02787601T patent/ATE361753T1/de active
- 2002-11-07 KR KR1020047004779A patent/KR20050044318A/ko not_active Application Discontinuation
- 2002-11-07 BR BR0212915-9A patent/BR0212915A/pt not_active Application Discontinuation
- 2002-11-07 EA EA200400382A patent/EA007325B1/ru unknown
- 2002-11-07 GE GE5516A patent/GEP20074097B/en unknown
- 2002-11-11 AR ARP020104308A patent/AR037291A1/es unknown
-
2004
- 2004-03-25 IL IL161114A patent/IL161114A/en active IP Right Grant
- 2004-03-29 IS IS7199A patent/IS2484B/is unknown
- 2004-03-29 ZA ZA2004/02464A patent/ZA200402464B/en unknown
- 2004-03-30 HR HR20040303A patent/HRP20040303B1/xx not_active IP Right Cessation
- 2004-03-30 NO NO20041320A patent/NO20041320L/no not_active Application Discontinuation
- 2004-03-31 MA MA27602A patent/MA27071A1/fr unknown
- 2004-03-31 CO CO04030711A patent/CO5580790A2/es not_active Application Discontinuation
- 2004-03-31 EC EC2004005041A patent/ECSP045041A/es unknown
-
2005
- 2005-02-08 HK HK05101101A patent/HK1070561A1/xx not_active IP Right Cessation
-
2007
- 2007-07-30 CY CY20071101000T patent/CY1106765T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60230425D1 (de) | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege | |
| DE60142473D1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
| DE60114580D1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
| ATE390407T1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| DE60114808D1 (de) | Oberflächenbehandlung von medizinischer vorrichtung | |
| ATE276244T1 (de) | Replikationsinhibitoren des respiratorischen synzytialvirus | |
| ATE538096T1 (de) | Pyridinon-derivate zur behandlung von arteriosklerose | |
| DE50206657D1 (de) | Pharmazeutische zusammensetzung zur behandlung von multiple sklerose | |
| DE60232251D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von asthma | |
| DE10194333T1 (de) | Methode des Quantenrechnens | |
| DE60103137D1 (de) | Impstoff zur behandlung von atherosclerosis | |
| DE60217363D1 (de) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen-abhängigen erkrankungen | |
| DE50209278D1 (de) | Vorrichtung zur Behandlung einer medizinischen Flüssigkeit | |
| DK1196409T3 (da) | Respiratoriske syncytilvirusreplikationsinhibitorer | |
| DE60216275D1 (de) | Verwendung von mit azetidinon substituierten derivaten bei der behandlung der alzheimer-krankheit | |
| DE60100625D1 (de) | Verwndung von verbindungen mit 5-ht1a aktivität zur behandlung von krankheiten der äusseren retina | |
| ATE292134T1 (de) | Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE60325353D1 (de) | Behandlung von mukositis | |
| DK1443938T3 (da) | Dosisenhed omfattende en prostaglantinanalog til behandling af forstoppelse | |
| DE60238765D1 (de) | Carbamatverbindungen zur behandlung von schmerz | |
| DE60318327D1 (de) | Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe | |
| IS5951A (is) | 5HT1 mótlyf fyrir meðferð gegn þunglyndi | |
| DE60104791D1 (de) | Cyclobutendion-Derivate zur Behandlung von Artherosclerose | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |